| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/13/2001 | WO2001066098A2 Therapeutic uses of ppar mediators |
| 09/13/2001 | WO2001066089A2 Pharmaceutical compositions comprising cannabis |
| 09/13/2001 | WO2001066088A1 New self emulsifying drug delivery system |
| 09/13/2001 | WO2001066087A1 New self emulsifying drug delivery system |
| 09/13/2001 | WO2001066085A2 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 09/13/2001 | WO2001066081A2 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
| 09/13/2001 | WO2001028993A3 Tyrosine kinase inhibitors |
| 09/13/2001 | WO2001028497A3 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 09/13/2001 | WO2001019542A8 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 09/13/2001 | WO2001015733A3 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | WO2000062795A3 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 09/13/2001 | WO2000034780A8 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3? |
| 09/13/2001 | WO1997014683A3 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 09/13/2001 | US20010021772 Vascular endothelial growth factor |
| 09/13/2001 | US20010021758 Drugs, medical diagnosis |
| 09/13/2001 | US20010021715 Gastrointestinal disorders |
| 09/13/2001 | US20010021708 Acylurea compound containing imidazolidine ring |
| 09/13/2001 | US20010021400 Tanacetum parthenium extract and method of obtaining same |
| 09/13/2001 | US20010021397 Solvent extraction from yeast |
| 09/13/2001 | US20010021392 Such as ibuprofen |
| 09/13/2001 | US20010021379 Platelet-activating factor acetylhydrolase |
| 09/13/2001 | DE10010113A1 Isolation of collagen by extraction from sponge, giving product having cyclooxygenase inhibiting activity, useful for treating inflammatory diseases such as arthritis or skin inflammation |
| 09/13/2001 | CA2402315A1 Therapeutic uses of ppar mediators |
| 09/13/2001 | CA2402211A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | CA2402039A1 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| 09/13/2001 | CA2401857A1 New self emulsifying drug delivery system |
| 09/13/2001 | CA2401541A1 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | CA2401524A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | CA2401454A1 G-protein coupled receptors |
| 09/13/2001 | CA2401398A1 Dna encoding human acid-sensing ion channel bnac4 (asic4) |
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2400628A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | CA2400504A1 Composition for the treatment of heart failure |
| 09/13/2001 | CA2400401A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such |
| 09/13/2001 | CA2399943A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399921A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399913A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399111A1 New aza-indolyl derivatives |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/12/2001 | EP1132390A2 Diazepinoindoles as phophodiesterase inhibitors |
| 09/12/2001 | EP1132389A1 New aza-indolyl derivatives for the treatment of obesity |
| 09/12/2001 | EP1131467A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/12/2001 | EP1131463A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption |
| 09/12/2001 | EP1131445A1 Human phospholipases |
| 09/12/2001 | EP1131443A2 Human hydrolase proteins |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131425A2 Inflammation-associated genes |
| 09/12/2001 | EP1131357A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 09/12/2001 | EP1131341A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, it's selection, pharmaceuticial compositions and use |
| 09/12/2001 | EP1131340A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 09/12/2001 | EP1131334A1 Use of core 2 glcnac transferase inhibitors in treating inflammation |
| 09/12/2001 | EP1131327A1 Prostaglandin conjugates for treating or preventing bone disease |
| 09/12/2001 | EP1131326A1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 09/12/2001 | EP1131316A2 Improved chemical process and pharmaceutical formulation |
| 09/12/2001 | EP1131314A1 Compounds having cytokine inhibitory activity |
| 09/12/2001 | EP1131304A1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases |
| 09/12/2001 | EP1131301A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP1131294A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 09/12/2001 | EP1131291A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 09/12/2001 | EP1131135A1 Composition containing an analgesic and a xanthine cor a xanthine derivative |
| 09/12/2001 | EP1131091A1 Method of treating viral hemorrhagic fever |
| 09/12/2001 | EP1131086A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 09/12/2001 | EP1131050A1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 09/12/2001 | EP0820450B1 N-substituted azaheterocyclic carboxylic acids and alkylesters thereof |
| 09/12/2001 | EP0449856B1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 09/12/2001 | CN1312810A Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors |
| 09/12/2001 | CN1312800A Therapeutic biaryl derivatives |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312112A Cure-all ointment |
| 09/12/2001 | CN1312098A Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia |
| 09/12/2001 | CN1312092A Rheumatism treating oral capsule and plaster and their preparation method |
| 09/12/2001 | CN1070866C Superagonists and antagonists and superantagonists of H IL-6, and 3-D modelling method for their selection |
| 09/12/2001 | CN1070852C Process for preparing 14-o-acylate of aconite alkaloid type compounds |
| 09/12/2001 | CN1070699C Topical composition comprising N-acetye-L-cysteine |
| 09/11/2001 | US6288278 Benzene derived amino alcohols as drugs |
| 09/11/2001 | US6288267 Thioamide derivatives |
| 09/11/2001 | US6288241 Crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrple-2-acetamidoacetic acid guaiacyl ester (MED 15) |
| 09/11/2001 | US6288218 Detecting gene expression in sample; incubate nucleotide sequences and primers, allow hybridization and detect hybridization products |
| 09/11/2001 | US6288103 Monocyte chemoattractant proteins antagonist such as n-(3-chlorophenylsulphonyl)indole-2-carboxylic acid; antiinflammatory agents |
| 09/11/2001 | US6288092 Triaryl compounds |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288062 Interleukin and tumor necrosis factor inhibitors; antiinflammatory agents; rheumatic diseases; antiarthritic agents; respiratory system disorders |
| 09/11/2001 | US6288036 Bradykinin type peptides |
| 09/11/2001 | US6288029 Template assembled synthetic peptide effective to treat respiratory system disorders |
| 09/11/2001 | US6287860 Antisense inhibition of MEKK2 expression |
| 09/11/2001 | US6287794 Peptide having antithrombotic effect through reversible inhibition of blood coagulation factor; antiinflammatory agents; treatment of cardiovascular disorders |
| 09/11/2001 | US6287594 Oral liquid compositions |
| 09/11/2001 | US6287592 Aqueous drink composition comprising ibuprofen |
| 09/11/2001 | CA2230936C 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064896A2 Human enzyme molecules |
| 09/07/2001 | WO2001064889A2 Tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 09/07/2001 | WO2001064885A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064862A1 Human monoclonal antibodies against oxidized ldl receptor and medicinal use thereof |
| 09/07/2001 | WO2001064756A1 Salmon-origin chondroitin sulfate |